EUVIMEDEUVIMED entdecken
Crossref

Nab-paclitaxel exacerbates PD-1 antibody-associated immune myocarditis via the STAT1/Egr-1/Trp53-mediated ferroptosis pathway

Tingting Meng, Yan Zheng, Zhijun Guo

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.118488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Tingting Meng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, People's Republi…. Hauptthemen laut MEDLINE: Early Growth Response Protein 1, STAT1 Transcription Factor, Tumor Suppressor Protein p53, Paclitaxel. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combination therapy with immune checkpoint inhibitors and chemotherapy heightens cardiovascular toxicity, yet the mechanism of exacerbated cardiac injury is poorly understood. Here, we investigated the cardiotoxicity of anti-PD-1 antibody plus nab-paclitaxel, focusing on ferroptosis and the role of Egr-1 as a therapeutic target. In tumor-bearing C57BL/6J mice, the combination caused more severe left ventricular dysfunction, myocardial inflammation, and ferroptotic features than either agent alone. In NRVMs, IFN-γ dose-dependently triggered ferroptosis through STAT1 phosphorylation. Activated STAT1 bound the Egr1 promoter to drive Egr-1 expression; Egr-1 then translocated to the nucleus and upregulated Trp53, leading to p53 accumulation that suppressed SLC7A11/xCT, impaired glutathione synthesis, and caused lethal lipid peroxidation. Cardiac-specific Egr-1 knockout markedly alleviated cardiac dysfunction, inflammation, and SLC7A11 loss induced by anti-PD-1 alone or combined with nab-paclitaxel, effectively attenuating ferroptosis and toxicity. These findings reveal the IFN-γ/STAT1/Egr-1/Trp53/xCT axis as a key driver of cardiomyocyte ferroptosis, positioning Egr-1 as a key driver linking immune activation to ferroptosis and a promising target for preventing ICI-chemotherapy cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Growth Response Protein 1STAT1 Transcription FactorTumor Suppressor Protein p53PaclitaxelFerroptosisMyocarditisProgrammed Cell Death 1 ReceptorAnimalsMiceMice, Inbred C57BLMaleMice, KnockoutImmune Checkpoint InhibitorsRats

Stichwörter der Autor:innen

Anti-PD-1 antibodyCardiotoxicityEgr-1FerroptosisNab-paclitaxel

Substanzen

Early Growth Response Protein 1STAT1 Transcription FactorStat1 protein, mouseEgr1 protein, mouseTumor Suppressor Protein p53Trp53 protein, mousePaclitaxelProgrammed Cell Death 1 ReceptorPdcd1 protein, mouseImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, People's Republic of China.
  • Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, People's Republic of China; Shandong Provincial Key Medical and Health Discipline of J…
  • Intensive Care Unit, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong 250117, People's Republic of China. Electronic address: guozj@sd-canc…

Förderung

  • Natural Science Foundation of Shandong Province
  • National Science and Technology Major Project

Zitieren

APA

Meng, T., Zheng, Y., & Guo, Z. (2026). Nab-paclitaxel exacerbates PD-1 antibody-associated immune myocarditis via the STAT1/Egr-1/Trp53-mediated ferroptosis pathway. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118488

Vancouver

Meng T, Zheng Y, Guo Z. Nab-paclitaxel exacerbates PD-1 antibody-associated immune myocarditis via the STAT1/Egr-1/Trp53-mediated ferroptosis pathway. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118488

BibTeX
@article{Meng2026,
  author = {Meng, Tingting and Zheng, Yan and Guo, Zhijun},
  title = {Nab-paclitaxel exacerbates PD-1 antibody-associated immune myocarditis via the STAT1/Egr-1/Trp53-mediated ferroptosis pathway},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.118488}
}
Kostenlos starten →